The bacterial cytosine deaminase (CD) gene converts the non-toxic prodrug 5-fluorocytosine (5-FC) into 5-fluorouracil. We have previously shown, in a rat liver metastasis model from colon carcinoma, that intratumoral injection of a CD-expressing plasmid into the animals followed by 5-FC treatment results in the regression of the treated tumor as well as distant uninjected tumors. The aim of this study was to further analyze the mechanisms associated with tumor regression induced upon application of suicide CD/5-FC strategy. Tumor regression was associated with an increased apoptosis, the recruitment of natural killer cells, CD4-and CD8 T lymphocytes within the tumors and an increased expression of several cytokines/chemokines mRNAs. These data indicate that the CD/5-FC suicide strategy is associated with the triggering of cellular and molecular events leading to an efficient antitumor immune response involving both innate and acquired immunity.
Introduction
The liver is the major site of metastases from colorectal cancer, and hepatic metastases are generally responsible for the patient's death. 1, 2 Despite recent progress of chemotherapy, 3 surgical resection of hepatic metastases constitutes the only curative treatment, with a 5-year survival from 25 to 30%. 1 Since resection is applicable in only 10-20% of patients, many efforts have been devoted to the development of alternative treatments. In this context, cancer gene therapy constitutes a promising therapeutic approach. Among the different strategies, suicide gene therapy, which consists in the transfer within the tumor of a viral or bacterial gene able to convert a non-toxic compound into a lethal drug, 4 is particularly interesting for several reasons. First, this strategy results in a tumor-targeted chemotherapy, allowing to bypass the toxic side effects generally associated to systemic chemotherapy. Second, the existence of a local bystander effect allows to induce complete tumor regression despite a low gene transfer efficiency. 5, 6 Finally, regression of distant non-transfected tumors can also be observed because of the triggering of a systemic antitumor immune response, which results in the destruction of the suicide geneexpressing tumor and tumor antigen release (distant bystander effect). [7] [8] [9] [10] [11] [12] The induction of an antitumor immune response is essential for the treatment of a metastatic disease since introduction of the suicide gene in a single tumor can theoretically result in the regression of all the metastasis. According to the selected animal model and the applied suicide gene therapy system, T lymphocytes 9, 10 and natural killer (NK) cells 8, 11, 12 have been reported to be involved in distant antitumor effect.
Over the past several years, the use of naked DNA or in association with liposomes 13, 14 for in vivo gene transfer has significantly increased, and these non-viral vectors are now used, respectively, in 18 and 7.9% of the clinical trials worldwide. 15 Naked DNA and cationic liposomes are attractive for in vivo gene transfer because of their favorable characteristics, such as biodegradability, low toxicity and immunogenicity, versatility and simplicity of use. [16] [17] [18] The two major problems encountered with these vectors are the low gene transfer efficiency and the transient transgene expression. In this regard, suicide gene therapy appears as a strategy of choice for the use of nonviral vectors, as the low gene transfer efficiency can be compensated by the local bystander effect and transgene long-term expression is not absolutely required, as it can be relayed by immune system activation. 19 The bacterial cytosine deaminase (CD) gene encodes an enzyme that when expressed in mammalian cells, is capable of converting the non-toxic anti-fungal agent 5-fluorocytosine (5-FC) into the widely used chemotherapeutic drug 5-fluorouracil (5-FU). 20 We have previously demonstrated, in rats bearing experimental metastases in the right and left liver lobes, that intratumoral injection of a CD-expressing plasmid into one of the tumors followed by 5-FC treatment results in regression of both lesions. 21 Moreover, this treatment induced a potent distant bystander effect on extrahepatic metastases, resulting in an increased survival compared to control animals.
In the present study, we analyzed the therapeutic efficiency of the CD gene transfer within liver metastases using naked DNA or plasmid DNA complexed with cationic liposomes in the presence of transferrin (Tflipoplexes), followed by 5-FC treatment. Moreover, the cellular and molecular events associated with the antitumor response induced by the CD/5-FC treatment were investigated by analyzing tumor cell death, tumorinfiltrating immune cells and tumor cytokine microenvironment.
Materials and methods

Plasmid
The pCDbgeo plasmid contains the CD gene under the control of the cytomegalovirus promoter, and a neo-lacZ fusion gene located downstream the phosphoglycerate kinase promoter. 12 Plasmid DNA was prepared using the Qiagen endo-free plasmid mega kit (Qiagen, Courtaboeuf, France), according to the manufacturer's instructions.
Antibodies
Mouse monoclonal antibodies against NK cells (NKR-P1A, 10-78, Pharmingen, BD Biosciences, Le Pont de Claix, France), CD4 T-cells (CD4, CL003AP, Cedarlane, Burlington, ON, Canada) and CD8 T-cells (CD8, CL004AP, Cedarlane) were used for immunohistological analysis. The isotype antibody (mouse IgG, I-2000, Vector Lab, Burlingame, CA) was used as negative control. Labeling was performed with biotinylated goat anti-mouse immunoglobulins (BD Biosciences) and streptavidinhorseradish peroxidase (HRP) conjugate (Pharmingen).
Cell culture DHD/K12/PROb (PROb) cells constitute a colon carcinoma cell line originated from a chemically induced colon cancer in BDIX rats. 22 These cells are poorly immunogenic and induce progressive and metastatic tumors in syngenic hosts. PROb cells were maintained in Dulbecco's modified Eagle medium (Invitrogen, Cergy Pontoise, France) supplemented with 10% fetal calf serum. For generation of liver tumors, cells were trypsinized, washed and resuspended at 15 Â 10 6 cells/ml in cold phosphatebuffered saline (PBS). One hundred microliters of cell suspension was used for each subcapsular injection.
Preparation of cationic liposomes and transferrin cationic liposome-DNA complexes (Tf-lipoplexes) Small unilamellar cationic liposomes were prepared by extrusion of multilamellar liposomes (MLV) composed of a 1:1 (mole ratio) mixture of 1,2-dioleoyl-3-(trimethylammonium) propane (DOTAP) and cholesterol (Chol). Briefly, lipids (Avanti Polar Lipids, Alabaster, AL) dissolved in CHCl 3 were mixed at the desired molar ratio and dried under vacuum in a rotatory evaporator. The dried lipid film was hydrated with deionized water to a final lipid concentration of 20 mM and the resulting MLV were then sonicated for 3 min, and extruded 21 times through two stacked polycarbonate filters of 50 nm pore diameter using a Liposofast device (Avestin, Toronto, ON, Canada). Tf-lipoplexes were prepared by sequentially mixing 21 ml of an HBS (HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffered saline) solution (100 mM NaCl, 20 mM HEPES, pH 7.4) containing human transferrin (Sigma, St Louis, MO;150 mg/ml), with 45.5 ml liposomes and incubated for 15 min at room temperature. DNA solution containing 100 mg of pCDbgeo was added to the mixture to a final volume of 100 ml and further incubated for 15 min at room temperature. 23 
Experimental protocols
For all the experiments, adult (9-week-old) BDIX male rats weighing 200-250 g (IFFA CREDO, L'arbresle, France) were used. All the surgical procedures and the care given to the animals were in accordance with institutional guidelines. Animals were randomly assigned to the different treatments.
Induction of liver tumors. After anesthetization and analgesia of the rat, the liver was surgically exposed and 1.5 Â 10 6 PROb tumor cells were injected under the Glisson's capsule using a 27-gauge needle, to generate experimental liver metastases.
Intratumoral injection of naked DNA or Tf-lipoplexes. Fifteen days after tumor cell injection, the rats were submitted to surgery, the liver was exposed and 100 ml of plasmid DNA solution in saline (1 mg/ml) or 100 ml of Tf-lipoplexes were directly injected into the tumor using a 27-gauge needle.
Treatment with 5-FC. 5-FC (10 mg/ml in water) was given orally for 30 days ad libitum.
Evaluation of tumor volume. Tumors were removed, sliced, measured with calipers in the two perpendicular diameters (a and b). The tumor volume was calculated according to the formula ab 2 p/6, as described previously. 24 Immune response induced by suicide gene therapy S Bertin et al TUNEL assay DNA fragmentation as an index of apoptosis was detected by terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL) using a DeadEnd Colorimetric TU-NEL Assay kit (Promega), according to the manufacturer's instructions. Briefly, 6 mm cryosections of tumors were fixed for 15 min in 4% (v/v) paraformaldehyde and then washed twice with PBS for 5 min. Sections were incubated with proteinase K (20 mg/ml) for 20 min at room temperature and further washed twice in PBS. Slices were further incubated for 10 min with equilibration buffer (200 mM potassium cacodylate (pH 6.6), 25 mM Tris-HCl (pH 6.6), 0.2 mM dithiothreitol, 0.25 mg/ml bovine serum albumin, 2.5 mM CoCl 2 ) before incubation for 1 h at 371C in a humidified chamber with dTdT reaction mixture prepared according to the manufacturer's instructions (Biotinylated Nucleotides, equilibration buffer and rTdT enzyme). The reaction was stopped by immerging the slices in standard saline citrate solution (0.3 M NaCl, 0.67 M sodium citrate, pH 7.2). Endogenous peroxidases were blocked with 0.3% H 2 O 2 solution for 5 min before incubation with streptavidin-HRP during 30 min at room temperature. For visualization, the sections were treated with 0.05% diaminobenzidin solution containing 0.01% H 2 O 2 . Samples were mounted with Dako medium (Dako, Glostrup, Denmark) and TUNELpositive apoptotic nuclei were observed by light microscopy in a Zeiss Axioscope microscope and identified by the presence of dark brown staining.
Immunohistological analysis
Six-micrometer cryosections of tumors were fixed in acetone for 5 min at À201C. Endogenous biotin was blocked with 5% goat serum and 10% streptavidin (blocking kit, Vector Lab, Abcys, Paris, France) in PBS buffer for 30 min at room temperature and endogenous peroxidase activity was quenched using 3% H 2 O 2 for 10 min at room temperature. NK cells and CD8-or CD4-T cells were detected by overnight incubation at 41C with monoclonal antibodies in antibody diluent and 10% biotin (Vector Lab). After washing in PBS, slices were incubated with a biotin-conjugated antibody for 1 h at room temperature, washed and subsequently incubated with streptavidin-HRP. After washing, positive cells were visualized using HRP substrate from a commercial kit (VIP, Vector Lab). Finally, slices were counterstained with hematoxylin and treated with mounting medium (VectaMount, Vector Lab) before observation.
RNA extraction and RPA assay PROb tumors were reduced into powder mechanically in liquid nitrogen and total RNA was extracted using TRIzol reagent (Invitrogen), according to the manufacturer's instructions. Integrity of the RNA was checked in 1% agarose gel and quantification was carried out by absorption at 260 nm. RNase protection assay (RPA) was performed with RiboQuant Multi-Probe RNase Protection Assay kits (BD Biosciences), according to the manufacturer's instructions. Briefly, [ After hybridization, 20 ng RNase A and 60 U RNase T1 were added to digest unhybridized RNA for 45 min at 301C. Proteinase K (12 mg) was then added to the sample and the mixture was further incubated at 371C for 15 min. At the end of the incubation, the sample was extracted with phenol/chloroform and ethanol precipitated. The pellet, containing the duplex RNA hybrids was loaded on a 5% polyacrylamide gel under denaturating conditions (7 M urea). Gels were dried and exposed to X-ray film at À701C for varying periods of time. Densitometry analysis was performed using Scion Image software (Scion Corporation, Frederick, MD).
Statistical analysis
For animal experiments, the results are expressed as median (95% confidence intervals (CI)). Comparison of tumor volumes between treated and control rats was performed using the Mann and Whitney's test, which is a non-parametric, two-tailed probability test. For RPA, statistical analysis of the results was performed using Student's t-test. P-values were considered to be statistically significant when less than 0.05 in experiments comparing two groups of animals, or less than 0.012 in experiments comparing four groups of animals (Bonferroni's correction).
Results
Intratumoral injection of CD-expressing plasmid alone or complexed with cationic liposomes followed by 5-FC treatment induces a significant antitumor effect To analyze the therapeutic potential of Tf-lipoplexes containing the CD-expressing plasmid compared to plasmid DNA alone, DHD/K12/PROb (PROb) rat colon carcinoma cells were injected under the liver capsule in the left and right lobes of 35 rats. After intrahepatic injection, PROb cells induce rapidly growing liver tumors as well as distant metastases in extra hepatic compartments. Fifteen days later, the rats were randomized in four groups, underwent surgery, and the presence of the PROb tumor was checked visually. The tumor volume at the beginning of treatment is around 6 mm 3 . In the control group (n ¼ 9), rats were injected with a saline medium in the left lobe tumor. In the second group (n ¼ 10), rats were injected in the left lobe tumor with the pCDbgeo plasmid expressing the CD gene and then treated orally for 30 days with 5-FC (DNA þ 5-FC group). In the remaining animals (n ¼ 16), Tf-lipoplexes containing the pCDbgeo plasmid were injected in the left lobe tumor. Among these rats, seven were then treated for 30 days with 5-FC (DNA þ lipo þ 5-FC group), while the remaining nine animals did not receive any additional treatment (DNA þ lipo group). At day 45, all animals underwent surgery and liver tumors were removed. The volume of liver tumors in each group is presented in Figure 1 . The median volumes of the injected tumors were 714.4 mm 3 (95% CI ¼ 452-747) and 358.8 mm 3 (95% CI ¼ 212-694) in control and DNA þ lipo group, respectively. However, no statistically significant difference between these two groups (P ¼ 0.16) was found, indicating that injection of Tf-lipoplexes in the absence of treatment with 5-FC has no effect on the growth of PROb tumors.
In the DNA þ 5-FC group, the median volume of the injected tumor was 62.8 mm 3 (95% CI ¼ 26-183), showing that the treatment resulted in a 91.2% reduction of the median tumor volume compared to the control group (P ¼ 0.0005), while in the DNA þ lipo þ 5-FC group, the median volume of the injected tumor was 117.6 mm 3 (95% CI ¼ 52-169), indicating a 83.5% decrease in the median tumor volume compared to the saline group (P ¼ 0.001). There was no significant difference in the median volume of the injected tumor between the DNA þ 5-FC group and the DNA þ lipo þ 5-FC group (P ¼ 0.49).
Regarding the uninjected right-lobe liver tumors, the median volumes were 550.7 mm 3 (95% CI ¼ 400-986) in the control group, 329.2 mm 3 (95% CI ¼ 121-731) in the DNA þ lipo group, 71.2 mm 3 (95% CI ¼ 29-160) in the DNA þ 5-FC group and 66.9 mm 3 (95% CI ¼ 5-160) in the DNA þ lipo þ 5-FC group. In the DNA þ 5-FC group and in the DNA þ lipo þ 5-FC group, the treatment resulted in 88.6% (P ¼ 0.0004) and 87.9% (P ¼ 0.0015) reduction, respectively, of the median tumor volume compared to the control group. No significant difference was found between saline and DNA þ lipo groups (P ¼ 0.12) and between DNA þ 5-FC and DNA þ lipo þ 5-FC groups (P ¼ 0.85). Representative photographs of tumors from control (saline and DNA þ lipo groups) and treated groups (DNA þ 5-FC and DNA þ lipo þ 5-FC groups) are shown in Figure 2 . Although no statistically significant reduction was observed regarding the occurrence of wound metastases and peritoneal carcinomatosis between treated and control groups, these metastases exhibited reduced tumor volumes (wound metastases) and dissemination (peritoneal carcinomatosis) in treated animals (data not shown).
CD gene transfer and 5-FC treatment induce tumor cell apoptosis CD/5-FC suicide gene therapy system has been reported to induce tumor cell death through apoptosis in various tumor models. [25] [26] [27] In the present work, we investigated whether the tumor regression observed in the experi- Immune response induced by suicide gene therapy S Bertin et al mental model of liver metastasis, upon application of the different treatments, was associated with tumor cell apoptosis. TUNEL staining has been used extensively to identify cells with nuclear DNA fragmentation and, therefore, this assay was selected for these studies. In control tumors (saline group), cells were essentially negative for TUNEL staining (Figure 3a) , while in the DNA þ lipo group, although a few apoptotic cells could be detected, the number was rather low, which indicates low toxicity of the lipoplexes (Figure 3b) . In contrast, a large number of apoptotic cells were observed in tumors from the treated groups (DNA þ 5-FC and DNA þ lipo þ 5-FC) (Figures 3c and d) , no significant difference being observed between the two treated groups.
CD gene transfer and 5-FC treatment are associated with an increased infiltration of NK cells, CD4-and CD8-T cells
To further analyze the observed antitumoral effect, immune cell infiltration was analyzed within the tumors at the end of the 5-FC treatment. As shown in Figure 4 , immunohistological analysis of the injected liver tumors revealed an increased infiltration of NK cells, CD4-and CD8-T cells in the treated groups (DNA þ 5-FC and DNA þ lipo þ 5-FC) compared to control groups (saline and DNA þ lipo). Only a few NKR-P1-positive and CD4-positive cells were present within tumors of control animals (that is, saline and DNA þ lipo groups), whereas tumors in treated rats (DNA þ 5-FC and DNA þ lipo þ 5-FC) were heavily infiltrated by these cell types. No difference was found in the NK cell infiltration between saline and DNA þ lipo groups or between DNA þ 5-FC and DNA þ lipo þ 5-FC groups. A similar number of CD4-positive cells was also found in the two treated groups. However, CD4-T cell infiltration was slightly more extensive in the DNA þ lipo group as compared to saline.
Tumor regression is associated with an increase in cytokine expression We then analyzed the tumor microenvironment by investigating mRNA expression for 18 cytokines and 2 chemokines using the RPA. Three to six tumors in each experimental group were individually analyzed, and the relative expression level of each cytokine compared to the saline control group is presented in Figure 5 . As observed, all the cytokines and cytokine-related molecules significantly overexpressed in the DNA þ 5-FC group, that is, IL-1b, IL-1Ra, IL-18, IFN-g, TGF-b1, TGF-b2 and TGF-b3, are also induced in the DNA þ lipo þ 5-FC group, except IL-1Ra, whose expression is not significantly increased in the latter group. The chemokine Lt-b is also overexpressed in the tumors from the treated groups. Intratumoral administration of Tf-lipoplexes, without further 5-FC treatment, induces a 1.5-fold increase in IL-1b and IL-18 expression levels as well as a 1.8-fold increase in that of TGF-b1 as compared to saline injection. The expression levels for IL-1a, IL-6, IL-10, IL-12p40, IFN-b, TNF-a, TNF-b and GM-CSF were under the detection limit independently of the tested condition, no significant modulation being observed of MIF mRNA expression. We also observed a 1.6-fold increase in monocyte chemoattractant protein-1 (MCP-1) protein levels in tumors from the DNA þ 5-FC group compared to tumors from the control group (data not shown).
Discussion
Our results clearly show that intratumoral injection of the CD-expressing plasmid, either naked or complexed with cationic liposomes in the presence of transferrin, followed by 5-FC administration results in a significant regression of the injected tumor. The absence of any enhancement in the therapeutic effect upon DNA complexation with the cationic liposomes suggests that the strong local bystander effect, associated with CD/5-FC suicide gene therapy system, 19, 27 masks the benefit associated to an increased gene transfer efficiency. Application of this strategy also results in an antitumor immune response as evidenced by the concomitant volume decrease of the controlateral liver tumor. This immune activation induces an increase in tumor infiltration of NK cells, CD4-and CD8-T cells in the treated animal groups compared to control groups. Lt-b is strongly induced in the treated tumors with a eightfold increase in mRNA levels. Lt-b is a C chemokine known to attract CD4 and CD8T lymphocytes as well as NK cells. Additionally, this chemokine is expressed in lymphocytes and NK cells, this expression being essentially activation-dependent. 28 We can thus speculate that tumor cell death activates resident T and/or NK cells, Immune response induced by suicide gene therapy S Bertin et al leading to the production of Lt-b, which in turn attracts more of these immune cells. Moreover, it has been previously demonstrated that lymphotactin expression improves therapeutic efficacy of CD suicide gene therapy in established murine colon carcinoma. 29 We also observed an increased expression of MCP-1 in treated tumors. This member of the CC chemokine family has been described to induce the migratory and cytotoxic activities of NK cells 30, 31 and to significantly increase the therapeutic efficiency of suicide gene therapy in an hepatocellular carcinoma mouse model. 32 In addition to these chemokines, tumors from treated groups exhibit an increase in mRNA levels of different cytokines, this being more pronounced for TGF-b, and particularly for TGF-b2, whose mRNA levels increased 8-and 9.7-fold, respectively, in DNA þ 5-FC and DNA þ lipo þ 5-FC groups. The role of TGF-b in the process of tumor formation is complex, both in tumor suppression and promotion, its effects varying either between tumors arising in different organs or between tumors in different stages of progression. 33 Nevertheless, the TGF-b signaling pathway is a tumor-suppressor pathway frequently inactivated in colon cancer, and inactivation of the TGF-b receptor type II in intestinal epithelial cells has been shown to induce invasion and malignant transformation of adenomas initiated by Apc mutation. 34 In addition, TGF-b has been described to upregulate Lt-b mRNA expression. 35 Our results show a moderate increase in the levels of IL-1b and IL-1Ra mRNAs in treated tumors. The IL-1 family of molecules consists of IL-1a and IL-1b, a specific receptor antagonist IL-1Ra and two different receptors IL-1RI and IL-1RII. 36 IL-1b is known to play a dual role in tumor progression by inducing an immunostimulatory environment, thus favoring an immune response or leading to a chronic inflammation by acting as a tumor growth factor with proangiogenic effects. 37 The balance between IL-1 and the decoy receptor IL-1Ra in local tissues is responsible for the physiological or pathophysiological IL-1 effects. 36 IL1Ra is able to inhibit IL-1b-induced vascular endothelial growth factor secretion 38 and xenograft growth in IL-1-producing tumors. 39 Further studies will be needed to understand the precise role of IL-1b and IL-1Ra mRNA increase observed during tumor regression. In the treated animals, we also observed an increase in mRNA expression of IL-18 (2.5-and 2.8-fold in DNA þ 5-FC and DNA þ lipo þ 5-FC groups, respectively) and IFN-g (1.7-fold in both treated groups), two major proinflammatory cytokines. IL-18 is a member of the IL-1 family and was originally identified as IFN-g-inducing factor. 40 Although many different cell types have been reported to express IFN-g, the most important sources for IFN-g are Figure 5 Tumor cytokine microenvironment analyses by RPAs. (a) Total RNA was extracted from tumors, and Multi-Probe RNase Protection Assay was performed to determine the mRNA expressions of IL-1b, IL-1Ra, IL-18, IFN-g, Lt-b, TGF-b1, TGF-b2 and TGF-b3. L32 that encodes an ubiquitously expressed ribosome subunit protein was used as internal control for normalization. Densitometry analysis of the blot is shown in (b). Three to six tumors per condition were analyzed and the results are expressed as ratio (mean7s.d.) of the studied gene relative to L32. Mean values obtained in the control (saline) condition were assigned the value of 1 (arbitrary units). *A significant difference (Po0.05) compared with saline group. IL, interleukin; IFN, interferon; Lt-b, lymphotactin-b; RPA, RNase protection assay; TGF, transforming growth factor. 41 It has also been demonstrated that depletion of these regulatory T cells delays the growth of PROb tumors and cures rats bearing established PROb tumors when followed by an immunotherapy which has no curative effect when administered alone. 41 These data suggest that our treatment overcomes, at least transiently, the tolerogenic effect of regulatory T cells. Taken 
